Valuing “ Lives Saved ” vs . “ Life - Years Saved ”
نویسنده
چکیده
There is long-standing debate whether to count “lives saved” or “life-years saved” when evaluating policies to reduce mortality risk. Historically, the two approaches have been applied in different domains. Environmental and transportation policies have often been evaluated using lives saved, while life-years saved has been the preferred metric in other areas of public health including medicine, vaccination, and disease screening. For benefit-cost analysis, the monetary value of risk reductions can be calculated either by multiplying expected lives saved by the “value per statistical life” (VSL) or by multiplying expected life-years saved by the “value per statistical life-year” (VSLY).
منابع مشابه
Saving lives versus life-years in rural Bangladesh: an ethical preferences approach.
Using a random sample of individuals in rural Bangladesh, this paper investigates people's ethical preferences regarding relative values of lives when it comes to saving lives of individuals of different ages. By assuming that an individual has preferences concerning different states of the world, and that these preferences can be described by an individual social welfare function, the individu...
متن کاملEvaluation of the Ethiopian Millennium Rural Initiative: Impact on Mortality and Cost-Effectiveness
MAIN OBJECTIVE Few studies have examined the long-term, impact of large-scale interventions to strengthen primary care services for women and children in rural, low-income settings. We evaluated the impact of the Ethiopian Millennium Rural Initiative (EMRI), an 18-month systems-based intervention to improve the performance of 30 primary health care units in rural areas of Ethiopia. METHODS We...
متن کاملScreening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa
BACKGROUND In 2015 South Africa established a national cryptococcal antigenemia (CrAg) screening policy targeted at HIV-infected patients with CD4+ T-lymphocyte (CD4) counts <100 cells/ μl who are not yet on antiretroviral treatment (ART). Two screening strategies are included in national guidelines: reflex screening, where a CrAg test is performed on remnant blood samples from CD4 testing; and...
متن کاملEflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola.
OBJECTIVE To compare the cost-effectiveness of eflornithine and melarsoprol in the treatment of human African trypanosomiasis. METHOD We used data from a Médecins Sans Frontières treatment project in Caxito, Angola to do a formal cost-effectiveness analysis, comparing the efficiency of an eflornithine-based approach with melarsoprol. Endpoints calculated were: cost per death avoided; incremen...
متن کاملCost-effectiveness analysis of screening modalities for breast cancer in Japan with special reference to women aged 40-49 years.
Although the introduction of screening mammography in Japan would be expected to reduce mortality from breast cancer, the optimal screening modality in terms of cost-effectiveness remains unclear. We compared the cost-effectiveness ratio, defined as the cost required for a life-year saved, among the following three strategies: (1) annual clinical breast examination; (2) annual clinical breast e...
متن کامل